Home Recalls D-0077-2021
Class II · Moderate risk Terminated Initiated Nov 1, 2020 (6 years ago)
Metformin HCl Extended Release Tablets USP 500 mg, Generic for : Glucophage XR, Pkg Size…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
What was recalled
Metformin HCl Extended Release Tablets USP 500 mg, Generic for : Glucophage XR, Pkg Size 100, Mfg: Time-Cap Labs, Inc.; Farmingdale, NY, NDC #: 68788-6932-1, Preferred Pharmaceuticals, Inc.
Recalling firm Preferred Pharmaceuticals, Inc.
Origin CA, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-0077-2021
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Class II · Moderate risk Ongoing Jun 12, 2026
Reason CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been…
Class II · Moderate risk Ongoing Mar 13, 2025
Reason CGMP Deviations
Class II · Moderate risk Ongoing Feb 25, 2025
Reason Presence of Foreign Tablets/Capsules.
Class II · Moderate risk Terminated Dec 30, 2024
Reason Presence of Foreign Tablets/Capsules: A Paracetamol 500 mg tablet was found in a 1000-count bottle of Metformin HCL ER Tablets USP, 500 mg.
Class II · Moderate risk Terminated Feb 22, 2023
Reason CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.